Sunday, March 27, 2016

Exploitation of Indian health care industry is being aggressively focused

The global pharma industries who are into the segment of life saving drug manufacturing are playing the game of capitalisms and are busy in printing money rather than saving life. Being an journalist I strongly resist on the issue. Anti-diversion programme this is the law which is being used by the foreign pharma companies to play with human life. This law acts in this fashion where the patients will only get the drug if they can provide identification, proof of citizenship and residency.  This will prevent many people from accessing the drug as well as will create lot of problem for the patients who are busy focusing on saving their loved ones. Many doctors will shy away from prescribing and will create more rumors of non availability of the drug. Further drug mafia’s will get a place to play indirectly as they have unlimited scales to reach anywhere.   I find that this Anti-diversion programme and the pressure on the Indian government regarding IPR changes are being designed to increase the income inequality among the Indians. Indians are increasing their wealth and are trying to increase the GDP growth. In such condition restriction on drugs and medicines will create massive problem at the ground levels which will lead to further problem for the people in terms of macro factors. This will lead to widening of income inequality, more deaths due to non affordability and also insurance companies will find a substantial hit in the long term. Drugmakers and their lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) which have made some of the strongest representations to the US government against India's IPR regime.

Further its being found that Indian government is being pressured and also many legal actions are being floated against the Indian pharma companies so that the Indian IPR act could be modified and could be modified where they can control the generic drug market. They want decade of patent orders on their product which are highly priced and also beyond common man reach. The Indian generic drug segment helps many Indians to access medicines which becomes to their affordability. This is a clear study of exploitation of resources   in a country like India where 60% of the population don’t have proper access to health care facilities. Share holders profits and exponential growth is busy in changing the landscape of the world. People will die but they will not get medicine unless they are at the affordable levels hence these Anti-diversion programme will create massive problems rather than solving. Just imagine that if in case of polio this law have been adopted then imagine the condition of India and other countries.  Overseas foreign companies are pressuring the Indian governments to adopt this law and also to incorporate changes in the IPR act.

I find that Indian population is being taken as a field of exploitation where in case of health. US have kept India in high alert place due to IPR since they want changes. The same is applicable in case of Europe. They want Indian markets to be controlled and make the income inequality widen among Indians who are working hard to fill up the gap. US drugmakers have three major problems with India's patent law - Section 3(d) and Section 84 of the Indian Patents Act, and absence of a period of exclusive marketing rights when a new drug gets regulatory approval. Under Section 3(d), new forms of existing medicines can't be patented unless they improve therapeutic efficacy. Section 84 allows issuing a compulsory licence to meet the reasonable requirements of the public at a reasonably affordable price. A compulsory license can also be granted under Section 92 of the Act in case of a national emergency.

Just like food medicine is a necessity. Further with increasing pollution and life style diseases have taken new shapes and dimensions hence the demand for cheap and proper affordable health care is required globally. Laws like Anti-diversion programme creates end for the global health care industry to improve. Every pharma companies will try for become billionaire at the cost of human life. FDI investments are good but not at the cost of Indian life.

0 comments:

  © Blogger template 'Minimalist H' by Ourblogtemplates.com 2008

Back to TOP